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A Case of an Atypical, Community Acquired Pneumonia:
A Case Summary and Topic Review
David P. Cork MS IV, Joanne Kim MD, Jie Cui, MD
Case Report

A 59 year old gentleman with a past medical history of
hypertension, hyperlipidemia, anxiety, depression, arthritis,
and hypothyroidism presented with a five day history of fever
to 102º F. He complained of a three-day history of nausea,
vomiting, and non-bloody, loose diarrhea, all of which had
been persistent and worsening over the past week. Over the
past two days, the patient had felt short of breath, and presented
in a state of severe dyspnea. He had experienced an indolent
course of illness, but was now concerned with his tachynpea and
wheezing, and he had developed a productive cough with a small
amount of yellow-brown sputum. He denied any hemoptysis
as well as recent travel or sick contacts. On admission, the
patient was taking hydrochlorothiazide, lisinopril, atorvastatin,
levothyroxine and fluoxetine. He was also using over-thecounter ibuprofen for arthritic pain.

Figure 1. Imaging upon admission
Chest x-ray – A bilateral infiltrative process is seen consuming the
majority of the right lung.

The patient was a smoker with a ten pack-year history. He
denied intravenous drug use and occasionally drank alcohol.
Family history was significant for paternal obstructive lung
disease and coronary artery disease. On review of systems, the
patient denied having a sore throat or any nasal congestion.
Vital signs upon presentation were temperature 101.0º F,
pulse 110 beats per minute, respiratory rate 40 breaths per
minute, blood pressure 125/68 mmHg, and pulse oximetry of
86% on a non-rebreather mask. Upon physical examination,
the patient was in moderate respiratory distress and unable to
talk in complete sentences. He appeared mildly confused, but
was awake, alert, and oriented. Jugular venous distention was
not recognized. His cardiovascular exam was significant for
tachycardia, but was without murmurs, rubs, or gallops. His
pulmonary exam demonstrated coarse breath sounds bilaterally
with diffuse, rhonchi throughout all lung fields. His abdomen
was soft, mildly distended with moderate obesity, and was
without hepato-splenomegaly. He had no lower extremity
edema and his musculoskeletal exam was grossly normal. His
skin was warm and moist, with good capillary refill (<2 sec).
Laboratory studies upon admission demonstrated electrolyte
abnormalities, including a sodium of 125 mmol/L, chloride of
91 mmol/L, blood urea nitrogen of 83 mmol/L and creatinine of
5.6 mmol/L. His complete blood count was within normal limits.
Blood gas demonstrated a pH of 7.22 carbon dioxide pressure of
45 mmHg, and oxygen pressure of 69 mmHg. Cardiac enzymes
were negative and brain natriuretic peptide was 43.9 ng/L.
His coagulation studies were within normal limits, as was his
thyroid stimulating hormone. A urinalysis showed a slightly
cloudy specimen with mild proteinuria. Clostridium difficile
antigen was negative.
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Figure 2. CT Chest without contrast – As the images move
superiorly to inferiorly, note the dense consolidation of the right
upper and lower lobes, as well as the groundglass appearance to
the infiltrative process of the left upper lobe.
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The patient was intubated in the Emergency Department due
to severe dyspnea, hypoxia, and respiratory failure. Blood,
urine and stool cultures were obtained. The patient was started
on empiric antibiotic coverage for signs of possible systemic
inflammatory response system with consolidative pneumonia
with pipercillin-tazobactam, vancomycin, and azithromycin.
Given the patient’s history of diarrhea, dyspnea, mild confusion,
and hyponatremia, a Legionella urine antigen was also sent. The
patient was admitted to the medical Intensive Care Unit, and
nephrology and infectious disease services were consulted.
The patient’s urine Legionella antibody assay returned positive,
and antibiotic coverage was then narrowed to azithromycin.
Treatment was planned for 21 days. After nine days of ventilatory
support, the patient was weaned and extubated without
complication. Upon questioning, the patient explained that he
had recently been working to remodel his bathroom, including
removing a finished bath tub which was designed to lay a top
the previous tub. The oldest tub was full of stagnate water which
had been pooled there for approximately six months before this
planned bathroom remodel. This added a potential source of
Legionella infection to the overall clinical story.

Figure 3. CXR upon extubation – There has been interval
clearance of the infiltrative process of the right lung. Residual
patchy infiltrates remain in the left lung base and right middle
and lower lobes.

Introduction to Legionella and Legionnaire’s Disease
Background

First identified in Philadelphia in 1976, Legionella has become
recognized as a common atypical pathogen. Legionella
is ubiquitous and classified as a fastidious gram-negative
coccobacilli, representing a genus with over fifty subgroups.
L. pneumophila comprises at least sixteen different subgroups,
many of which require very specific culture growth media.
Legionellosis refers to two clinical syndromes caused by the
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genus Legionella: 1) Legionnaire’s disease, a syndrome of
pneumonia, and 2) Pontiac fever, an acute febrile illness that
tends to be self-limited in nature.

Epidemiology

Legionella is noted as one of the top four causes of community
acquired pneumonia (CAP) amongst the immunocompromised
population, and is a common culprit of hospital-associated
pneumonia. In fact, the incidence of Legionella as a cause of
sporadic community-acquired pneumonia ranges from 2-15%
of all cases requiring admission to a hospital.�

Transmission of Disease

Transmission of Legionella is accomplished by way of aerosol
inhalation or by micro-aspiration of water contaminated with
the organism.1 Cooling towers, ultrasonic mist machines such
as those used by grocery stores, respiratory equipment, and
whirlpool baths have been commonly cited as vectors for disease
transmission. Water distribution systems in nursing homes,
workplaces, and private residences have each been implicated as
primary sources of Legionellosis. Indeed, potable water sources
have been associated with numerous reports of Legionella
infection. The species L. pneumophila is capable of infecting and
replicating in various protozoa found in soil and water, and may
have increased virulence if replication occurs within amoeba.1
Due to L. pneumophila’s virulence, Legionella pneumonia is
recognized as manifesting a more severe pneumonia than other
bacteria commonly associated with CAP.
The group of atypical CAP represents systemic infectious diseases
that can primarily or secondarily infect the lungs. Atypical CAP
differs from CAP in the way the specific bacteria infect host
cells. Atypical bacteria are facultative intracellular organisms
most susceptible to tetracylines, macrolides, or quinolones.
Indeed, Legionella species are capable of exponential multiplication within human monocytes and alveolar macrophages.
An intact cellular immune response is thus necessary to inhibit
intracellular replication, with use of activated macrophage and
monocyte cell-mediated immunity. Patients with immunesuppression have neutrophil ingestion of the organisms
after complement and antibody have targeted the organism,
but often are unable to effectively kill the bacteria. 2 Typical
pneumonias more commonly are comprised of organisms that
invade interstitial spaces between cells and trigger neutrophil
activation with cytokine release, thereby activating a generalized
and immediate immune response.

Risk Factors and Disease Manifestations

Underlying disease is a major risk factor for acquisition of this
disease. The risk factors most commonly implicated are cigarette
smoking, chronic lung disease, and immunosuppression.
Severely immunocompromised patients are said to fare worse
in terms of disease severity, which may include lung abscess and
bacteremia. They are also at risk for extra-pulmonary infections
including sinusitis, pancreatitis, peritonitis, pyelonephritis, and
most commonly, cardiac manifestations such as myocarditis,
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Table 1. Common Clinical Features of Legionnaire’s Disease
Organ Involved

Common Features

Argues Against Legionnaires’ Disease

Central Nervous System

Confusion

Meningeal Signs

Upper Respiratory Tract

None

Sore throat, ear pain, bullous myringitis, otitis media

Cardiac

Relative bradycardia

Splenomegaly

Gastrointestinal

Loose, watery stools

Hepatic tenderness, RLQ pain, LUQ tenderness,
peritoneal signs

Renal

Renal insufficiency

CVA tenderness, chronic renal failure

pericarditis, postcardiotomy syndrome, and endocarditis
(Table 1).3 Nasogastric tubes have been implicated as sources
of nosocomial legionellosis as well.1 Also, patients who have
recently undergone head and neck surgery, and therefore
are susceptible to aspiration, have been noted as an at-risk
population.1 Common clinical features of community-acquired
pneumonias include: cough, fever, pleuritic chest pain, sputum
production, and dyspnea. Scant sputum production is more
typical of atypical community-acquired pneumonias, whereas
typical pneumonias contracted within the community are more
commonly characterized by mucopurulent sputum production.

Differential Diagnosis

• Chlamydia pneumonia
• Mycoplasma pneumonia
• Fungal pneumonia
• Viral pneumonia
• Q Fever
• Psittacosis

Owing to its potential degree of severity and its resistance
to beta-lactam antibiotic therapy, Legionella represents the
most important nonzoonotic CAP pathogen to differentiate
from CAP pathogens.2 With observation of commonalities
amongst patients infected with Legionella, it is possible to
make presumptive diagnoses based on clinical presentation.
Therefore, it is important to keep in mind the following differentiating features frequently seen with Legionella infection
when narrowing a differential diagnosis:
a. relative bradycardia in the context of a febrile illness
1. limits diagnosis to Legionella, Q fever, and psittacosis
b. unexplained mental confusion, including cerebellar ataxia
c. loose, watery stools

Clinical Diagnosis

Pneumonia is the predominant clinical syndrome. The disease
may represent a broad spectrum of illnesses though, ranging
from mild cough to respiratory failure. Typically seen early in
the disease course are non-specific symptoms and signs such as

fever, malaise, myalgias, headache, and anorexia.1 Cough tends
to be only slightly productive, and temperature commonly
exceeds 104º F. Diarrhea may be seen in approximately 25%
of cases, with complaints of watery rather than bloody stools;3
loose, watery diarrhea was reported in approximately 6% of other
types of community-acquired pneumonias. 3 Other common
characteristic findings are relative bradycardia, which is most
common among the elderly or those with advanced disease
states and hyponatremia (serum sodium levels less than 130
mg/dL). Additionally, in patients demonstrating an increased
cold agglutinin titer, which is commonly checked for suspected
mycosplasma infections, the diagnosis of Legionella pneumonia
is essentially ruled out. Due to the variance in severity of disease,
as well as specialized lab tests required to confirm the diagnosis,
Legionellosis is often underdiagnosed.5
The most important test for Legionnaire’s disease is the
isolation of the organism by culture on buffered charcoal yeast
extract. Obtaining adequate sputum for culture can often be
problematic in these patients however. When Legionnaire’s
is considered or suspected, a urine antigen test, Legionella
culture, and a direct fluorescent antibody (DFA) staining from
sputum or tissues should be considered. Indirect immunofluorescence assay (IFA) and/or enzyme-linked immunosorbent
assay (ELISA) are also possible, but are not as useful in clinical
decision making, as increased titers over four to eight weeks
are required for confirmatory diagnoses (a fourfold rise in
the titer of serum IgG antibody to L. pneumophila with final
titer of at least 1/128 is commonly considered positive). 6 The
urine antigen test is an enzyme immunoassay with sensitivity
of approximately 70%, and nearly 100% sensitivity;7 this test
however applies to L. pneumophila serotype 1, which represents
only 80-90% of Legionella infections.7 In contrast, the DFA test
(sensitivity 33-68%, specificity 99-100%) can be performed in a
manner of a few hours.8 ELISA tests are generally preferred over
IFA tests nowadays, due to reportedly improved sensitivities
(80% and 70%, respectively).8,9 Unfortunately this type of serum
testing also lacks sensitivity for detecting serotypes other than
serotype 1, as with the urine tests.

Treatment

Quinolones or doxycyline remain first-line therapy. Delay
in initiation of treatment significantly increases mortality.1
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Table 2. Non-Specific Laboratory Tests
Nonspecific Laboratory Tests

Common Features

Argues Against Legionaire’s Disease

Gram stain (sputum)

Few mononuclear cells, few/no bacteria

Purulent sputum, single predominant organism

White Blood Cell Count

Leukocytosis, relative lymphopenia

Leucopenia, thrombocytosis, thrombocytopenia

Pleural Fluid

Exudative

Red blood cells, decreased pH, decreased glucose

Aminotransferases

Mildly elevated (2-5x normal)

Markedly elevated (10x normal)

Serum Phosphorus

Decreased (early)

Normal value does not rule out Legionnaire’s Disease

Creatine Phosphokinase

Increased (early)

Normal value does not rule out Legionnaire’s Disease

C-Reactive Protein

Increased (early)

Normal value does not rule out Legionnaire’s Disease

Ferritin

Highly elevated (>2x normal)

Normal/slightly increased early. Normal value does not rule
out Legionnaire’s Disease

Cerebral Spinal Fluid

No pleocytes

Red blood cells, decreased glucose, decreased lactate

Urinalysis

Microscopic hematuria

Gross hematuria, pyuria, hemoglobinuria

Stool

Watery stools

Blood or mucus

Treatment duration is two weeks with quinolones, or two to
four weeks with other antibiotics.1 Another treatment option is
macrolides, however there is variability between drug efficacy in
this class for eradicating Legionella. For instance, erythromycin
has been associated with therapy failures.1 Other macrolides,
such as azithromycin are said to have better in vitro activity and
improved pulmonary tissue penetration.1 Overall, quinolones
have improved in vitro activity and intracellular penetration
compared to macrolides. In patients who are severely ill,
rifampin is recommended as an adjunct in combination therapy
with a macrolide or quinolone, as it has high levels of activity
against Legionella. Imipenem, trimethoprim-sulfamethoxazole,
and clindamycin have all been proven efficacious for the
treatment of Legionella pneumonia. 9 Treatment of the
underlying pneumonia will improve the associated diarrhea,
electrolyte abnormalities, and other associated syndromes seen
with Legionnaire’s Disease.

Prognosis

Patients with Legionnaire’s Disease usually experience
symptomatic improvement within three to five days if treated
early with an effective antibiotic. With early treatment and
appropriate drug choice, the mortality rate for immunocompromised patients approaches that of immuno-competent
patients.10 However, mortality can vary widely and is noted
to be as high as 80% in cases, particularly in patients with
underlying disease where lack of prompt recognition and
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treatment initiation exist, and in nosocomial or large outbreaks.
Decreasing mortality trends have been noted recently due
to increased awareness and consideration of the disease as a
possible infectious etiology.
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